Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Buy
2,957
+37
+1% +$4.33K 0.29% 61
2026
Q1
$351K Buy
2,920
+10
+0.3% +$1.15K 0.3% 55
2025
Q4
$306K Sell
2,910
-82
-3% -$7.7K 0.26% 60
2025
Q3
$251K Buy
2,992
+1
+0% +$82 0.19% 64
2025
Q2
$237K Sell
2,991
-117
-4% -$9.3K 0.2% 63
2025
Q1
$279K Buy
+3,108
New +$290K 0.26% 55

Other funds holding MRK

North Capital's MRK Position: Q2 2026 in Review

North Capital increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $4.33K and bringing the position to 2,957 shares worth $380K. The position accounts for 0.29% of the portfolio, ranked #61.

North Capital first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • North Capital held 2,957 shares of Merck worth $380K as of Q2 2026.
  • North Capital bought 37 Merck shares in Q2 2026, an estimated $4.33K.
  • Merck made up 0.29% of North Capital's portfolio in Q2 2026, its #61 holding.
  • North Capital first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on North Capital's 13F filing for Q2 2026, filed 14 Jul 2026.